Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: Peptides. 2014 Dec 30;64:55–61. doi: 10.1016/j.peptides.2014.12.005

Table I. Binding to BBR.

IC50, μM
Ligand BRS3 GRPR NMBR NCI-H727
BA1 0.006 ± .001 0.0004 ± .0001 0.0025 ± .0003 0.004 ± .001
EMY-98 >100 >100 >100 >100
GRP >10 0.0003 ± 0.0001 0.150 ± 23 >10
ML-18 4.8 ± 0.6 16 ± 2 >100 6.4 ± 1.1
NMB >10 0.060 ± .008 0.0007 ± .0001 >10

The mean IC50 ± S.D. of 3 determinations is indicated to inhibit specific 125I-BA1 binding to NCI-H727 lung cancer cells or cells transfected with BRS-3, GRPR or NMBR.